Search

everythinglearnresearchcommunity

for

Search:↓

Treating ovarian-related inflammation may help hair regrowth in women with alopecia areata.

New cancer treatments aim to reduce side effects and improve effectiveness.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

No treatment is completely effective for alopecia totalis and alopecia universalis.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Thyroid-related genes are active in skin cells and may affect autoimmune conditions.

Nanotechnology could improve treatment for scars and atopic dermatitis by targeting skin issues more effectively.

Controlling cellular changes can enable safe rejuvenation without cancer risk.

Radiotherapy can cause skin fibrosis, which is often overlooked and needs better treatment and evaluation.

Alopecia areata was successfully treated with contact immunotherapy, oral antihistamines, and topical corticosteroids.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

Corticosteroids regrow hair better and faster than pentoxifylline for alopecia areata.

Janus kinase inhibitors are the most supported treatment for pediatric alopecia areata, while other options have limited evidence.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Small molecule treatments improve the ability of human amniotic fluid stem cells to become different cell types.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

New treatments for Alopecia Areata, like JAK inhibitors, are effective, and future research is exploring advanced therapies.

IL-18 signaling helps mature Tregs move into the thymus.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Topical corticosteroids are the best initial treatment for children with Alopecia Areata.